Empowered Choices: “The Most Important Conversations” Oncologists Can Have With NSCLC Patients

When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate Jill Feldman. In the second episode of the LungCancerRx video podcast, cohosts Fawzi F. Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit; Eric K. Singhi, MD, a thoracic oncologist in Houston; and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center, ask Feldman about how physicians can better empower patients when making difficult therapy choices. “I started using ‘informed decision-making’ because you cannot have ‘shared decision-making’ if patients aren’t completely informed,” she explains.